Michael G. Cannon
CEO Veteran Medical Technology

Michael Cannon is a veteran medical technology CEO in the field of cardiovascular imaging. Cannon led the founding of Ecton, Inc. (sold to Acuson Corporation), and Penrith Corporation (sold to Siemens), and he was an early employee in sales and marketing and business development at Interspec, Inc., a pioneer in portable echocardiography. Companies and products he has managed have been recognized as leaders in advancing the capability and clinical reach of ultrasound worldwide. Ecton developed the world’s first portable digital, phased array cardiac ultrasound system. Penrith developed the world’s first ultrasound system with wireless transducers, using a novel internally-developed high data rate ultra-wideband radio. Ecton is the subject of a Clayton Christensen Harvard Business School Case Study still in widespread use. Since September 2016 Cannon has worked as Senior Advisor to Bay Labs, Inc., a leading artificial intelligence startup working on advanced cardiovascular imaging and interpretation. Among other roles, at Bay Labs, Cannon has been at the forefront of developing regulatory pathways for deep learning products. He is also active in a number of university technology transfer initiatives in cardiology. Cannon holds multiple patents with several pending, including machine learning related ones.

Back to Speakers

Buy now